http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-203483718-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd1f583871320ad42c3df038ce51c5a2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-168
filingDate 2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06977f468cb2bfae0422a9d8a3ca6a49
publicationDate 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-203483718-U
titleOfInvention Three-channel intravenous anesthesia control instrument
abstract The utility model relates to medical devices, in particular to a three-channel intravenous anesthesia control instrument used for intravenous anesthesia injection. The three-channel intravenous anesthesia control instrument is composed of three sets of injection devices of the same structure. Each injection device is internally provided with a syringe, wherein a remnant detection photoelectric switch, a specification recognition photoelectric switch and a piston detection photoelectric switch are installed on the outer portion of a tube body of the syringe respectively, the three photoelectric switches are connected with an ARM respectively, a push rod at the tail end of the syringe is pushed by a motor which is connected with the ARM through a motor driving board, a photoelectric coded disk is installed on the push rod and connected with the ARM, and the ARM is externally connected with three control panels which are connected with and control the three sets of injection devices respectively. The three-channel intravenous anesthesia control instrument has the advantages of being high in timing precision, stable in flow velocity, few in liquid dosage and particularly suitable for injecting medicine for symptoms. The medicine for the symptoms includes the sodium nitroprusside medicine, the dopamine medicine, the propofol medicine and the antibiosis medicine.
priorityDate 2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11963579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448847757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681

Total number of triples: 17.